相关实验视频
Updated: May 26, 2025
09:41
Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
55.0K
系统性粉症的支持性护理:国际粉症协会 (ISA) 专家小组指南
Eli Muchtar1, Martha Grogan2, Fabian Aus dem Siepen3
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
概括
系统性amyloidosis支持性护理指南提供了建议,以管理症状和改善这种罕见的蛋白质错折障碍患者的生活质量. 这些指导方针涉及心脏病学,病学,神经学和其他关键领域,以支持患者在治疗期间.
科学领域:
- 血液学和内科医学
- 罕见疾病 罕见疾病
- 蛋白质错误折叠障碍 蛋白质错误折叠障碍
背景情况:
- 系统性amyloidosis是一组罕见的蛋白质错折障碍,其特点是器官中的粉样蛋白沉积.
- 粉样蛋白沉积会导致逐渐的器官功能障碍,衰竭,如果不治疗,可能导致死亡.
- 虽然特定类型的治疗针对潜在原因,但支持性护理对于管理症状和改善结果至关重要.
研究的目的:
- 为患有全身性amyloidosis的患者提供基于证据的支持性护理建议.
- 解决关键领域包括心脏病学,病学,神经学 (外周和中枢神经系统,自主神经病变),胃肠病学,血液学,营养学和凝血病学.
- 为了提高患者的生活质量,并可能在疾病导向治疗期间延长生存期.
主要方法:
- 国际粉症协会 (ISA) 代表相关医学领域的国际专家制定指南.
- 为支持性护理策略收集最好的可用证据和临床专业知识.
- 专注于系统性氨基粉症患者管理的八个关键领域.
主要成果:
- 针对系统性粉样症影响的多个器官系统的支持性护理的综合建议.
- 指南旨在减少症状负担,改善生活质量,并可能延长存活时间.
- 强调支持性措施与类型特定治疗相辅相成的重要作用.
结论:
- 支持性护理是治疗全身性粉样化症的重要组成部分,是针对性治疗的补充.
- 这些ISA指南为优化跨越各种临床挑战的患者护理提供专家共识.
- 有效的支持性护理可以减轻并发症,降低医疗保健成本,改善患者整体预后.
更多相关视频
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
57
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
57
03:03Amyloid Fibrils
5.1K
5.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89
01:28Pleural Effusion II: Symptoms and Management
148
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
148